GUFICBIO.NSE logo

GUFICBIO.NSE
Gufic Biosciences Ltd.

58
Loading...
Loading...
News
all
press releases
News Placeholder
India Mucormycosis Treatment (Black Fungus Drugs) Market to Get an Explosive Growth | Natco Pharmaceuticals, Alembic Pharmaceuticals, Gufic Biosciences
The India Mucormycosis Treatment (Black Fungus Drugs) market is estimated to be valued at USD 9.1 Mn in 2025 and is expected to reach USD 11.7 Mn by 2032, growing at a compound annual growth rate CAGR of 3.5% from
News Placeholder
India Mucormycosis Treatment (Black Fungus Drugs) Market to Get an Explosive Growth | Natco Pharmaceuticals, Alembic Pharmaceuticals, Gufic Biosciences
The India Mucormycosis Treatment (Black Fungus Drugs) market is estimated to be valued at USD 9.1 Mn in 2025 and is expected to reach USD 11.7 Mn by 2032, growing at a compound annual growth rate CAGR of 3.5% from
News Placeholder
India Mucormycosis Treatment (Black Fungus Drugs) Market Projected To Witness Massive Growth, 2025-2032 | Natco Pharmaceuticals, Alembic Pharmaceuticals, Gufic Biosciences
The qualitative latest Research report (2025-2032) on the India Mucormycosis Treatment (Black Fungus Drugs) Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and
News Placeholder
India Mucormycosis Treatment (Black Fungus Drugs) Market Projected To Witness Massive Growth, 2025-2032 | Natco Pharmaceuticals, Alembic Pharmaceuticals, Gufic Biosciences
The qualitative latest Research report (2025-2032) on the India Mucormycosis Treatment (Black Fungus Drugs) Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and
<
...
1
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available